Updated Jul 16, 2026
Eizen Joshua M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $53K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-10 | ANTX | AN2 Therapeutics, Inc. | S — Open-market sale | 5.9K | $4.17 | $25K |
| 2026-02-23 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 50.0K | $0.00 | |
| 2026-01-08 | ANTX | AN2 Therapeutics, Inc. | S — Open-market sale | 6.9K | $1.01 | $7K |
| 2026-01-08 | ANTX | AN2 Therapeutics, Inc. | S — Open-market sale | 17.9K | $1.00 | $18K |
| 2025-11-06 | ANTX | AN2 Therapeutics, Inc. | S — Open-market sale | 2.8K | $1.14 | $3K |
| 2024-11-05 | ANTX | AN2 Therapeutics, Inc. | A — Grant or award | 31.5K | $0.00 |
Eizen Joshua M is a corporate insider — currently tracked as Insider of AN2 Therapeutics, Inc. (ANTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($53K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Eizen Joshua M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.